Rapidly accumulating literature has proven feasibility of the zebrafish xenograft models in cancer research. Nevertheless, online databases for searching the current zebrafish xenograft literature are in great demand. Herein, we have developed a manually curated database, called ZenoFishDb v1.1 (https://konulab.shinyapps.io/zenofishdb), based on R Shiny platform aiming to provide searchable information on ever increasing collection of zebrafish studies for cancer cell line transplantation and patient-derived xenografts (PDXs). ZenoFishDb v1.1 user interface contains four modules: DataTable, Visualization, PDX Details, and PDX Charts. The DataTable and Visualization pages represent xenograft study details, including injected cell lines, PDX injections, molecular modifications of cell lines, zebrafish strains, as well as technical aspects of the xenotransplantation procedures in table, bar, and/or pie chart formats. The PDX Details module provides comprehensive information on the patient details in table format and can be searched and visualized. Overall, ZenoFishDb v1.1 enables researchers to effectively search, list, and visualize different technical and biological attributes of zebrafish xenotransplantation studies particularly focusing on the new trends that make use of reporters, RNA interference, overexpression, or mutant gene constructs of transplanted cancer cells, stem cells, and PDXs, as well as distinguished host modifications.
Get full access to this article
View all access options for this article.
References
1.
BosmaGC, CusterRP, BosmaMJ. A severe combined immunodeficiency mutation in the mouse. Nature, 1983; 301:527–530.
2.
ClemmesenJ.On transplantation of tumor cells to normal and pre—irradiated heterologous organisms. Am Assoc Cancer Res J, 1937; 29:313–332.
3.
GiovanellaBC, YimSO, StehlinJS, WilliamsLJJr. Development of invasive tumors in the “nude” mouse after injection of cultured human melanoma cells. J Natl Cancer Inst, 1972; 48:1531–1533.
4.
RygaardJ, PovlsenCO. Heterotransplantation of a human malignant tumour to “Nude” mice. Acta Pathol Microbiol Scand, 1969; 77:758–760.
5.
DayCP, MerlinoG, Van DykeT. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell, 2015; 163:39–53.
6.
RichmondA, SuY. Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech, 2008; 1:78–82.
7.
BultCJ, KrupkeDM, BegleyDA, RichardsonJE, NeuhauserSB, SundbergJP, et al.Mouse Tumor Biology (MTB): a database of mouse models for human cancer. Nucleic Acids Res, 2015; 43:D818–D824.
8.
ConwayT, WaznyJ, BromageA, TymmsM, SoorajD, WilliamsED, et al.Xenome—a tool for classifying reads from xenograft samples. Bioinformatics, 2012; 28:i172–i178.
9.
HeS, HuB, LiC, LinP, TangWG, SunYF, et al.PDXliver: a database of liver cancer patient derived xenograft mouse models. BMC Cancer, 2018; 18:550.
10.
KluinRJC, KemperK, KuilmanT, de RuiterJR, IyerV, FormentJV, et al.XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data. BMC Bioinformatics, 2018; 19:366.
11.
ConteN, MasonJC, HalmagyiC, NeuhauserS, MosakuA, YordanovaG, et al.PDX Finder: a portal for patient-derived tumor xenograft model discovery. Nucleic Acids Res, 2019; 47:D1073–D1079.
LeeLM, SeftorEA, BondeG, CornellRA, HendrixMJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn, 2005; 233:1560–1570.
14.
ZhangB, XuanC, JiY, ZhangW, WangD. Zebrafish xenotransplantation as a tool for in vivo cancer study. Fam Cancer, 2015; 14:487–493.
15.
BrownHK, SchiavoneK, TazzymanS, HeymannD, ChicoTJ. Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opin Drug Discov, 2017; 12:379–389.
16.
DrabschY, Snaar-JagalskaBE, Ten DijkeP. Fish tales: The use of zebrafish xenograft human cancer cell models. Histol Histopathol, 2017; 32:673–686.
17.
ZhaoC, WangX, ZhaoY, LiZ, LinS, WeiY, et al.A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS One, 2011; 6:e21768.
18.
XiongP, XiaoLY, YangR, GuoQ, ZhaoYQ, LiW, et al.Flotillin-1 promotes cell growth and metastasis in oral squamous cell carcinoma. Neoplasma, 2013; 60:395–405.
19.
ThomasC, RajapaksaG, NikolosF, HaoR, KatchyA, McCollumCW, et al.ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res, 2012; 14:R148.
20.
HalaszM, PolgarB, BertaG, CzimbalekL, Szekeres-BarthoJ. Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity. Cell Mol Life Sci, 2013; 70:4617–4630.
21.
HerreraJ, BeisangDJ, PetersonM, ForsterC, GilbertsenA, BenyumovA, et al.Dicer1 deficiency in the idiopathic pulmonary fibrosis fibroblastic focus promotes fibrosis by suppressing microRNA biogenesis. Am J Respir Crit Care Med, 2018; 198:486–496.
BansalN, DavisS, TereshchenkoI, Budak-AlpdoganT, ZhongH, SteinMN, et al.Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate, 2014; 74:187–200.
28.
JungIH, ChungYY, JungDE, KimYJ, Kim doH, KimKS, et al.Impaired lymphocytes development and xenotransplantation of gastrointestinal tumor cells in Prkdc-Null SCID zebrafish model. Neoplasia, 2016; 18:468–479.
29.
Martinez-OrdonezA, SeoaneS, CabezasP, EiroN, Sendon-LagoJ, MaciaM, et al.Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Oncogene, 2018; 37:1430–1444.
30.
WangH, SchaeferT, KonantzM, BraunM, VargaZ, PaczullaAM, et al.Prominent oncogenic roles of EVI1 in breast carcinoma. Cancer Res, 2017; 77:2148–2160.
31.
WuPC, LuJW, YangJY, LinIH, OuDL, LinYH, et al.H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis. Cancer Res, 2014; 74:7333–7343.
32.
ChiavacciE, RizzoM, PittoL, PatellaF, EvangelistaM, MarianiL, et al.The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs. Cytotechnology, 2015; 67:969–975.
33.
ChenC, ChoudhuryS, WangsaD, LescottCJ, WilkinsDJ, SripadhanP, et al.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug. Sci Rep, 2017; 7:11410.
34.
LinJ, ZhangW, ZhaoJJ, KwartAH, YangC, MaD, et al.A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy. Blood, 2016; 128:249–252.
35.
WuJQ, ZhaiJ, LiCY, TanAM, WeiP, ShenLZ, et al.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Exp Clin Cancer Res, 2017; 36:160.
36.
OthmanN, NagoorNH. miR-608 regulates apoptosis in human lung adenocarcinoma via regulation of AKT2. Int J Oncol, 2017; 51:1757–1764.
37.
CichonMA, SzentpeteryZ, CaleyMP, PapadakisES, MackenzieIC, BrennanCH, et al.The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma. Oncogene, 2014; 33:4185–4192.
38.
SchaeferT, WangH, MirP, KonantzM, PereboomTC, PaczullaAM, et al.Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget, 2015; 6:43540–43556.
39.
HuangCY, LeeCH, TuCC, WuCH, HuangMT, WeiPL, et al.Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis. Oncotarget, 2018; 9:9425–9441.
40.
CorkeryDP, ClarkeLE, GebremeskelS, SalsmanJ, PinderJ, Le PageC, et al.Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking. Oncogene, 2018; 37:174–184.
41.
ChapmanA, Fernandez del AmaL, FergusonJ, KamarashevJ, WellbrockC, HurlstoneA. Heterogeneous tumor subpopulations cooperate to drive invasion. Cell Rep, 2014; 8:688–695.
42.
de BoeckM, CuiC, MulderAA, JostCR, IkenoS, Ten DijkeP. Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model. Sci Rep, 2016; 6:24968.
43.
BrittoDD, WyrobaB, ChenW, LockwoodRA, TranKB, ShepherdPR, et al.Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model. Dis Model Mech, 2018; 11:dmm035998.
HeS, LamersGE, BeenakkerJW, CuiC, GhotraVP, DanenEH, et al.Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol, 2012; 227:431–445.
46.
SmithMP, FergusonJ, ArozarenaI, HaywardR, MaraisR, ChapmanA, et al.Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. J Natl Cancer Inst, 2013; 105:33–46.
47.
ChoSJ, KookMC, LeeJH, ShinJY, ParkJ, BaeYK, et al.Peroxisome proliferator-activated receptor gamma upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer. Int J Cancer, 2015; 136:810–820.
48.
von MassenhausenA, SandersC, BragelmannJ, KonantzM, QueisserA, VogelW, et al.Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib. Int J Cancer, 2016; 139:2359–2369.
49.
LiY, DrabschY, PujuguetP, RenJ, van LaarT, ZhangL, et al.Genetic depletion and pharmacological targeting of alphav integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res, 2015; 17:28.
50.
Gaytan-CervantesJ, Gonzalez-TorresC, MaldonadoV, ZampedriC, Ceballos-CancinoG, Melendez-ZajglaJ. Protein Sam68 regulates the alternative splicing of survivin DEx3. J Biol Chem, 2017; 292:13745–13757.
51.
Simbulan-RosenthalCM, DoughertyR, VakiliS, FerraroAM, KuoLW, AlobaidiR, et al.CRISPR-Cas9 knockdown and induced expression of CD133 reveal essential roles in melanoma invasion and metastasis. Cancers (Basel), 2019; 11:1490.
52.
JungJ, SeolHS, ChangS. The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat, 2018; 50:1–10.
53.
MitraA, MishraL, LiS. Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol, 2013; 31:347–354.
54.
CassidyJW, CaldasC, BrunaA. Maintaining tumor heterogeneity in patient-derived tumor xenografts. Cancer Res, 2015; 75:2963–2968.
55.
BarriusoJ, NagarajuR, HurlstoneA. Zebrafish: a new companion for translational research in oncology. Clin Cancer Res, 2015; 21:969–975.
56.
CollinsAT, LangSH. A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine. PeerJ, 2018; 6:e5981.
57.
EdenCJ, JuB, MurugesanM, PhoenixTN, NimmervollB, TongY, et al.Orthotopic models of pediatric brain tumors in zebrafish. Oncogene, 2015; 34:1736–1742.
58.
MercataliL, La MannaF, GroenewoudA, CasadeiR, RecineF, MiserocchiG, et al.Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a zebrafish model. Int J Mol Sci, 2016; 17:1375.
59.
FiorR, PovoaV, MendesRV, CarvalhoT, GomesA, FigueiredoN, et al.Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A, 2017; 114:E8234–E8243.
60.
BentleyVL, VeinotteCJ, CorkeryDP, PinderJB, LeBlancMA, BedardK, et al.Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica, 2015; 100:70–76.
61.
GaudenziG, AlbertelliM, DicitoreA, WurthR, GattoF, BarbieriF, et al.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors. Endocrine, 2017; 57:214–219.
62.
Banasavadi-SiddegowdaYK, WelkerAM, AnM, YangX, ZhouW, ShiG, et al.PRMT5 as a druggable target for glioblastoma therapy. Neuro Oncol, 2018; 20:753–763.
63.
MarquesIJ, WeissFU, VleckenDH, NitscheC, BakkersJ, LagendijkAK, et al.Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 2009; 9:128.
64.
BonnetD, DickJE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997; 3:730–737.
65.
BaiocchiM, BiffoniM, Ricci-VitianiL, PilozziE, De MariaR. New models for cancer research: human cancer stem cell xenografts. Curr Opin Pharmacol, 2010; 10:380–384.
66.
ChenL, GroenewoudA, TulottaC, ZoniE, Kruithof-de JulioM, van der HorstG, et al.A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response. Methods Cell Biol, 2017; 138:471–496.
67.
EguiaraA, HolgadoO, BeloquiI, AbaldeL, SanchezY, CallolC, et al.Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification. Cell Cycle, 2011; 10:3751–3757.
68.
ZhangB, ShimadaY, KuroyanagiJ, AriyoshiM, NomotoT, ShintouT, et al.In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative, DiOC5(3). Biomaterials, 2015; 52:14–25.
StaalFJ, SpainkHP, FibbeWE. Visualizing human hematopoietic stem cell trafficking in vivo using a zebrafish xenograft model. Stem Cells Dev, 2016; 25:360–365.
71.
HamiltonN, SabroeI, RenshawSA. A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models. F1000Res, 2018; 7:594.
72.
HanHW, HsuSH. Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells. Acta Biomater, 2016; 42:157–167.
73.
MiH, DongQ, MuruganujanA, GaudetP, LewisS, ThomasPD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res, 2010; 38:D204–D210.
74.
MoshalKS, Ferri-LagneauKF, HaiderJ, PardhananiP, LeungT. Discriminating different cancer cells using a zebrafish in vivo assay. Cancers (Basel), 2011; 3:4102–4113.
75.
WelkerAM, JarosBD, AnM, BeattieCE. Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma. Neuroscience, 2017; 356:35–43.
76.
HayesMN, McCarthyK, JinA, OliveiraML, IyerS, GarciaSP, et al.Vangl2/RhoA signaling pathway regulates stem cell self-renewal programs and growth in rhabdomyosarcoma. Cell Stem Cell, 2018; 22:414–427.e6.
77.
KhanN, MahajanNK, SinhaP, JayandharanGR. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish. Blood Cells Mol Dis, 2019; 75:48–55.
78.
YanC, BrunsonDC, TangQ, DoD, IftimiaNA, MooreJC, et al.Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish. Cell, 2019; 177:1903–1914.e14.
79.
MacRaeCA, PetersonRT. Zebrafish as tools for drug discovery. Nat Rev Drug Discov, 2015; 14:721–731.
80.
CornetC, DyballaS, TerrienteJ, Di GiacomoV. ZeOncoTest: refining and automating the zebrafish xenograft model for drug discovery in cancer. Pharmaceuticals (Basel), 2019; 13:1.
81.
Vazquez RodriguezG, AbrahamssonA, JensenLDE, DabrosinC. Adipocytes promote early steps of breast cancer cell dissemination via interleukin-8. Front Immunol, 2018; 9:1767.
82.
Vazquez RodriguezG, AbrahamssonA, JensenLD, DabrosinC. Estradiol promotes breast cancer cell migration via recruitment and activation of neutrophils. Cancer Immunol Res, 2017; 5:234–247.
83.
MarranciA, D'AurizioR, VenckenS, MeroS, GuzzolinoE, RizzoM, et al.Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA. RNA Biol, 2019; 16:865–878.
84.
van der EntW, BurrelloC, TeunisseAF, KsanderBR, van der VeldenPA, JagerMJ, et al.Modeling of human uveal melanoma in zebrafish xenograft embryos. Invest Ophthalmol Vis Sci, 2014; 55:6612–6622.
85.
Timmermans-SprangEPM, MestemakerHM, SteenlageRR, MolJA. Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signalling. Vet Comp Oncol, 2019; 17:413–426.
86.
LinQH, QuW, XuJ, FengF, HeMF. 1-Methoxycarbony-beta-carboline from Picrasma quassioides exerts anti-angiogenic properties in HUVECs in vitro and zebrafish embryos in vivo. Chin J Nat Med, 2018; 16:599–609.
87.
FuA, PehYM, NganW, WeiN, LuoKQ. Rapid identification of antimicrometastases drugs using integrated model systems with two dimensional monolayer, three dimensional spheroids, and zebrafish xenotransplantation tumors. Biotechnol Bioeng, 2018; 115:2828–2843.
ShtamT, NaryzhnyS, SamsonovR, KarasikD, MizgirevI, KopylovA, et al.Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling. Breast Cancer Res Treat, 2019; 174:129–141.
90.
LawsonND, WeinsteinBM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol, 2002; 248:307–318.
91.
DrabschY, HeS, ZhangL, Snaar-JagalskaBE, Ten DijkeP. Transforming growth factor-beta signalling controls human breast cancer metastasis in a zebrafish xenograft model. Breast Cancer Res, 2013; 15:R106.
92.
ThompsonMA, RansomDG, PrattSJ, MacLennanH, KieranMW, DetrichHW 3rd, et al.The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol, 1998; 197:248–269.
93.
JinSW, BeisD, MitchellT, ChenJN, StainierDY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development, 2005; 132:5199–5209.
94.
WeiJ, ZhangJ, SiY, KanadaM, ZhangZ, TerakawaS, et al.Blockage of LMP1-modulated store-operated Ca(2+) entry reduces metastatic potential in nasopharyngeal carcinoma cell. Cancer Lett, 2015; 360:234–244.
95.
CorkeryDP, DellaireG, BermanJN. Leukaemia xenotransplantation in zebrafish—chemotherapy response assay in vivo. Br J Haematol, 2011; 153:786–789.
96.
AvciME, KeskusAG, TargenS, IsilakME, OzturkM, AtalayRC, et al.Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines. Sci Rep, 2018; 8:1570.
97.
ZhaoC, ZhangW, ZhaoY, YangY, LuoH, JiG, et al.Endothelial cords promote tumor initial growth prior to vascular function through a paracrine mechanism. Sci Rep, 2016; 6:19404.
98.
ChenX, WangJ, CaoZ, HosakaK, JensenL, YangH, et al.Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model. Sci Rep, 2015; 5:10351.
99.
HollenbachM, StollSJ, JorgensK, SeufferleinT, KrollJ. Different regulation of physiological and tumor angiogenesis in zebrafish by protein kinase D1 (PKD1). PLoS One, 2013; 8:e68033.
100.
SpenderLC, FergusonGJ, LiuS, CuiC, GirottiMR, SibbetG, et al.Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. Oncotarget, 2016; 7:81995–82012.
GabelliniC, Gomez-AbenzaE, Ibanez-MoleroS, TuponeMG, Perez-OlivaAB, de OliveiraS, et al.Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Int J Cancer, 2018; 142:584–596.
103.
GhotraVP, HeS, de BontH, van der EntW, SpainkHP, van de WaterB, et al.Automated whole animal bio-imaging assay for human cancer dissemination. PLoS One, 2012; 7:e31281.
104.
HamiltonL, AstellKR, VelikovaG, SiegerD. A zebrafish live imaging model reveals differential responses of microglia toward glioblastoma cells in vivo. Zebrafish, 2016; 13:523–534.
105.
WehmasLC, TanguayRL, PunnooseA, GreenwoodJA. Developing a novel embryo-larval zebrafish xenograft assay to prioritize human glioblastoma therapeutics. Zebrafish, 2016; 13:317–329.
106.
VittoriM, BreznikB, HrovatK, KenigS, LahTT. RECQ1 helicase silencing decreases the tumour growth rate of U87 glioblastoma cell xenografts in zebrafish embryos. Genes (Basel), 2017; 8:222.
107.
RampazzoE, PersanoL, PistollatoF, MoroE, FrassonC, PorazziP, et al.Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis, 2013; 4:e500.
108.
CaoY, HoeppnerLH, Bach SE G, GuoY, WangE, et al.Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial alpha5 integrin. Cancer Res, 2013; 73:4579–4590.
109.
TanDS, HaalandB, GanJM, ThamSC, SinhaI, TanEH, et al.Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer. Mol Cancer, 2014; 13:13.
110.
ChiangKC, HsuSY, LinSJ, YehCN, PangJH, WangSY, et al.PTEN insufficiency Increases breast cancer cell metastasis in vitro and in vivo in a xenograft zebrafish model. Anticancer Res, 2016; 36:3997–4005.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
